CD69 and colorectal carcinoma: As found in Ke et al.'s latest research, the expression of PD-1 and CD69 on effector memory CD8+ T cells in the blood can predict the presence of tertiary lymphoid structures (TLSs) in the macroscopic environment of CRC and serve as biomarkers for stratifying CRC patients for immunotherapy 72.